Marburg Virus Disease: Clinical Trials

10 trials for Marburg Virus Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 active not recruiting. 10 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 110Completed 9, Active not recruiting 1

Follow Marburg Virus Disease: new trials by email Literature Review of Marburg Virus Disease trials Research Report on Marburg Virus Disease

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health
rVSV∆G-MARV-GP, Placebo - Marburg Virus Disease
Phase 1Active not recruitingInternational AIDS Vaccine Initiative1122026-03-272026-10-30
Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects
PHV01, Placebo - Marburg Virus Disease
Phase 1CompletedPublic Health Vaccines LLC362024-02-052025-09-05
Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
cAd3-Marburg, cAd3-EBO-S - Ebola Virus Disease, Marburg Virus Disease
Phase 1CompletedAlbert B. Sabin Vaccine Institute322021-01-062022-08-03
A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430
galidesivir, placebo - Marburg Virus Disease
Phase 1CompletedBioCryst Pharmaceuticals322018-12-102021-07-23
cAd3-Marburg Vaccine in Healthy Adults
cAd3-Marburg vaccine - Marburg Virus Disease
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)402018-10-092022-08-11
A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers
Ad26 Zaire Ebola Vaccine, MVA Multi-Filo Ebola Vaccine - Ebola Disease, Marburg Disease
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)652017-03-242025-07-29
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers
AVI-7288, Placebo - Marburg Hemorrhagic Fever
Phase 1CompletedSarepta Therapeutics, Inc.402013-05-012014-05-07
Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
AVI-6003, Placebo - Marburg Hemorrhagic Fever
Phase 1CompletedSarepta Therapeutics, Inc.302011-05-012012-05-07
Evaluating an Ebola and a Marburg Vaccine in Uganda
Ebola vaccine, Marburg vaccine, Placebo injection - Ebola Virus Disease, Marburg Virus Disease
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1082010-02-012013-01-28
Ebola and Marburg Virus Vaccines
VRC-EBODNA023-00-VP, VRC-MARDNA025-00-VP - Ebola Vaccines, Marburg Virus Disease
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)202008-01-252017-07-02

Narrower conditions

Hemorrhagic Fever, Ebola (4)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Acquired angioedema (1)  ·  Angioedemas, Hereditary (1)  ·  Communicable Diseases (1)  ·  Creutzfeldt-Jakob Syndrome (1)  ·  Disseminated Intravascular Coagulation (1)  ·  Hemorrhagic Fevers, Viral (1)  ·  Hepatitis B (1)  ·  Hepatitis C (1)

Broader conditions

Animal Diseases (10)  ·  Filoviridae Infections (10)  ·  Infections (10)  ·  Monkey Diseases (10)  ·  Mononegavirales Infections (10)  ·  Primate Diseases (10)  ·  RNA Virus Infections (10)  ·  Virus Diseases (10)  ·  Hemorrhagic Fevers, Viral (9)  ·  Angioedema (1)  ·  Blood Coagulation Disorders (1)  ·  Blood-Borne Infections (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)

Interventions

AVI-7288 (1)  ·  Ebola Vaccines (1)  ·  Saline Solution (1)  ·  galidesivir (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (4)  ·  Sarepta Therapeutics, Inc. (2)  ·  Albert B. Sabin Vaccine Institute (1)  ·  BioCryst Pharmaceuticals (1)  ·  International AIDS Vaccine Initiative (1)  ·  Public Health Vaccines LLC (1)

Countries

United States (9)  ·  Uganda (1)

Top investigators

Alison Heald, MD (1)  ·  Apinya B Vutikullird, MD (1)  ·  Daniel Dickerson, MD, PhD (1)  ·  David Hoover, MD (1)  ·  Hannah Kibuuka, MBChB, MMed, MPH (1)  ·  Joan Fusco, PhD (1)  ·  Melinda Hamer, M.D. (1)  ·  Michael Stevenson, MD (1)  ·  Mohamed Al-Ibrahim, MD (1)  ·  Richard Kenney, MD (1)  ·  Roxana Rustomjee, MBChB (1)  ·  Tuan Le, MD (1)

Results publications

PMID 1538192, PMID 15577929, PMID 16375711, PMID 25225676, PMID 25426834, PMID 25540891, PMID 26200980, PMID 35182042, PMID 36709074, PMID 39715748, PMID 8237108

NIH funding

272201300017C-18-0-1 (1)